CH664957A5 - 4-Hydroxy-2-oxo-1-pyrrolidinyl-acetamide prodn. - Google Patents

4-Hydroxy-2-oxo-1-pyrrolidinyl-acetamide prodn. Download PDF

Info

Publication number
CH664957A5
CH664957A5 CH412685A CH412685A CH664957A5 CH 664957 A5 CH664957 A5 CH 664957A5 CH 412685 A CH412685 A CH 412685A CH 412685 A CH412685 A CH 412685A CH 664957 A5 CH664957 A5 CH 664957A5
Authority
CH
Switzerland
Prior art keywords
oxo
hydroxy
alkyl
acetic acid
ester
Prior art date
Application number
CH412685A
Other languages
German (de)
Inventor
Thomas Dr Meul
Original Assignee
Lonza Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza Ag filed Critical Lonza Ag
Priority to CH412685A priority Critical patent/CH664957A5/en
Priority to IL80071A priority patent/IL80071A0/en
Priority to EP86112952A priority patent/EP0216325A3/en
Priority to JP22177186A priority patent/JPS6272661A/en
Priority to ES8602069A priority patent/ES2001696A6/en
Priority to NO863769A priority patent/NO863769L/en
Priority to SU864028166A priority patent/SU1482525A3/en
Priority to DK453586A priority patent/DK453586A/en
Priority to HU864071A priority patent/HUT43039A/en
Priority to CS866880A priority patent/CS257294B2/en
Publication of CH664957A5 publication Critical patent/CH664957A5/en
Priority to US07/188,702 priority patent/US4824966A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • C07D207/382-Pyrrolones

Abstract

Prodn. of 4-hydroxy-2-oxo-1 -pyrrolidinylacetamide (I) is effected by (a) treating an alkyl 4-alkoxy-2-oxo -3-pyrroline-1-acetate of formula (II) either with an anhydrous acid or with MeSiCl3 in the presence of an alkali metal iodide to form an alkyl 2,4-dioxo-1 -pyrrolidinylacetate (III); (b) reducing (III) with NaBH4 to form an alkyl 4-hydroxy-2-oxo-1-pyrrolidinylacetate (IV); and (c) reacting (IV) with NH3c. In thormulae R1 = Me or Et; R2 = 1-4C alkyl. Pref. step (a) is effected with MeSiCl3 and NaI in MeCN or with HCl gas in anhydrous HOAc.

Description

       

  
 



   BESCHREIBUNG



   Die Erfindung betrifft ein neues Verfahren zur Herstellung des cerebral wirksamen 4-Hydroxy-2-oxo-pyrrolidin-1yl-acetamids. Es sind Verfahren zur Herstellung des obengenannten Wirkstoffes bekannt. Schlechte Ausbeuten und teure Ausgangsprodukte machen die Verfahren jedoch nicht rentabel.



   Es stellt sich daher die Aufgabe, einen Weg zu finden, der die genannten Nachteile ausschaltet.



   Gelöst wurde die Aufgabe erfindungsgemäss durch ein Verfahren nach Anspruch 1. Darin wird ein   4-(C1-C2)-alk-      oxy-3-pyrrolin-2-on-1-yl-essigsäure-(Cl-C4)-alkylester,    vorzugsweise   4-Methoxy-3-pyrrolin-2-on- 1 -yl-essigsäureethyl-    ester mit Trichlormethylsilan, in Gegenwart eines Alkalijodids, vorzugsweise mit Natriumjodid, umgesetzt.



   Das Molverhältnis der Edukte   4-(C1-C2)-alkoxy-3-pyrro-      lin-2-on- 1 -yl-essigsäure-(C1-C4)-alkylester    zu Trichlormethylsilan zu Alkalijodid wählt man zweckmässig zwischen 1 zu 1 zu 1 und 1 zu 2 zu 2, vorzugsweise zwischen 1 zu 1,2 zu
1,2 und 1 zu 1,6 zu 1,6.



   Vorteilhaft wird diese Umsetzung in einem Lösungsmit tel, besonders vorteilhaft in Acetonitril, durchgeführt.



   Die Umsetzungstemperatur liegt bevorzugt im Bereich der Rückflusstemperatur des Lösungsmittels.



   Nach einer Reaktionszeit von ca. 1 bis 5 Stunden und  üblicher Aufarbeitung durch z.B. Extraktion und gegebenen falls durch anschliessende Reinigung des Produktes durch   z.B.    Umkristallisation kann der entsprechende 2,4-Dioxo   pyrrolidin- 1 -yl-essigsäure-(C 1-C4)-alkylester    erhalten werden.



   Die Überführung der   2,4-Dioxo-pyrrolidin-1-yl-essigsäu-      re-(C1-C4)-alkylester,    speziell des Ethylesters, in das Zielmolekül   4-Hydroxy-2-oxo-pyrrolidin- 1 -yl-acetamid    durch Reduktion mit Natriumborhydrid und nachfolgende Amidierung mit Ammoniak wurde in der Literatur bereits vorexerziert.



   (G. Pifferi, M. Pinza, Jl Farmaco, Ed. Sc., 1977, 32, 602.) Das   4-Hydroxy-2-oxo-pyrrolidin- 1 -yl-acetamid    kann danach   ils    reines weisses Produkt in guter Ausbeute erhalten werden.



   Beispiel Herstellung von   2,4-Dioxo-pyrrolidin-1-yl-essigsäureetlzylester   
2,0 g (10 mmol)   4-Methoxy-3-pyrrolin-2-on-l-yl-essig-      säureethylester    und 2,1 g (14 mmol) Natriumjodid wurden in 20,0 ml Acetonitril gelöst. Anschliessend gab man 1,6 g (14 mmol) Trichlormethylsilan zu. Die gelblich gefärbte trübe Reaktionslösung wurde 4 Stunden unter Rückfluss er   hitzt.    Man liess auf Raumtemperatur abkühlen und dampfte das Lösungsmittel unter Wasserstrahlvakuum ab. Der Rückstand wurde in 50,0 ml Methylenchlorid aufgeschlämmt und mit einer Lösung aus 1,0 g   Natriumbissulfat    in 5,0 ml Eiswasser versetzt. Die wässrige Phase wurde dreimal mit je 50,0 ml Methylenchlorid extrahiert.

  Die vereinigten organi   jochen    Phasen wurden über Na2SO4 getrocknet, eingedampft und am Hochvakuum getrocknet.



   Man erhielt 1,9 g einer orangegefärbten Masse, die lang   sam    durchkristallisierte.



   Das umkristallisierte Produkt (Toluol:Petrolether 1:1)   schmolz    bei 92 bis 93   "C.   



   NMR   (CDCl3) 8    = 4,25 (s,   2H);    4,23 (q, J=7,1 Hz, 2H);   4,03      (t,J=1,0Hz,    2H); 3,11 (br.   s,2H);      1,30 (t, J=7,1    Hz, 3H).



  Herstellung von 4-Hydroxy-2-oxo-pyrrolidin-1-yl-essigsäureethylester
Zu 8,8 g (47,5 mmol) 2,4-Dioxo-pyrrolidin-1 -yl-essig   säureethylester    in 200 ml Dimethoxyethan wurden bei 0   "C    ),54 g (14,5 mmol) Natriumborhydrid zugegeben. Die Mischung wurde während einer Stunde bei Raumtemperatur gerührt. Nach Abkühlen auf 0   "C    wurde konzentrierte Salzsäure im Überschuss zugegeben und der anorganische Rückstand abfiltriert. Das Filtrat wurde zur Trockene eingedampft. Der Rückstand wurde in Chloroform aufgenommen, getrocknet über Na2SO4 und erneut unter Vakuum einbedampft.



   Es resultierten 8,8 g des Produktes in öliger Form.



   Eine anschliessende Destillation bei 180   "C/1,0    mbar Führte zu 5,3 g (60%) eines farblosen   Oles.   



   IR (Film)   3400cm-1    (OH);   1740 cm-l    (C=O);   1680 cm-'    (C=O);   1200 cm-l    Herstellung von   4Hydroxy-2-oxo-pyrrolidin-1-yl-acetamid   
13,7 g (73 mmol)   4-Hydroxy-2-oxo-pyrrolidin-1-yl-essig-      säureethylester    wurden gelöst in 500 ml Methanol und bei D   "C    mit Ammoniak gesättigt. Danach wurde während einer Stunde bei Raumtemperatur gehalten. Abdampfen des Lösungsmittels unter Vakuum führte zu einem festen Rückstand. Dieser wurde in Methanol kristallisiert.

 

   Es resultierten 7,17 g (62%) des Produktes in Form eines weissen Pulvers. Fp. 165 bis 168   "C.   



   IR (Nujol) 3400   cm-l,    3300   cm-',      3250 cm-    (OH und NH) 1660   cm-l    (C=O). 



  
 



   DESCRIPTION



   The invention relates to a new process for producing the cerebrally active 4-hydroxy-2-oxopyrrolidin-1yl-acetamide. Processes for producing the above-mentioned active ingredient are known. However, poor yields and expensive starting products do not make the processes profitable.



   The task is therefore to find a way that eliminates the disadvantages mentioned.



   The object was achieved according to the invention by a process according to claim 1. A 4- (C1-C2) alkoxy-3-pyrrolin-2-one-1-yl-acetic acid (Cl-C4) alkyl ester is preferred therein 4-methoxy-3-pyrrolin-2-one-1-ethyl acetate with trichloromethylsilane in the presence of an alkali iodide, preferably with sodium iodide.



   The molar ratio of the educts 4- (C1-C2) -alkoxy-3-pyrroline-2-one-1-yl-acetic acid (C1-C4) alkyl ester to trichloromethylsilane to alkali iodide is expediently chosen between 1: 1: 1 and 1 to 2 to 2, preferably between 1 to 1.2 to
1,2 and 1 to 1.6 to 1.6.



   This reaction is advantageously carried out in a solvent, particularly advantageously in acetonitrile.



   The reaction temperature is preferably in the range of the reflux temperature of the solvent.



   After a reaction time of approx. 1 to 5 hours and usual work-up by e.g. Extraction and if necessary by subsequent cleaning of the product by e.g. Recrystallization can be obtained from the corresponding 2,4-dioxopyrrolidin-1-yl-acetic acid (C 1 -C 4) alkyl ester.



   The conversion of the 2,4-dioxopyrrolidin-1-yl acetic acid (C1-C4) alkyl ester, especially the ethyl ester, into the target molecule 4-hydroxy-2-oxopyrrolidin-1-yl-acetamide Reduction with sodium borohydride and subsequent amidation with ammonia has already been pre-practiced in the literature.



   (G. Pifferi, M. Pinza, Jl Farmaco, Ed. Sc., 1977, 32, 602.) The 4-hydroxy-2-oxo-pyrrolidin-1-yl-acetamide can then be obtained in pure yield in a good yield will.



   Example Preparation of 2,4-dioxopyrrolidin-1-yl-ethyl acetate
2.0 g (10 mmol) of 4-methoxy-3-pyrrolin-2-one-l-yl-acetic acid ethyl ester and 2.1 g (14 mmol) of sodium iodide were dissolved in 20.0 ml of acetonitrile. Then 1.6 g (14 mmol) of trichloromethylsilane were added. The yellowish cloudy reaction solution was heated under reflux for 4 hours. The mixture was allowed to cool to room temperature and the solvent was evaporated off under a water jet vacuum. The residue was slurried in 50.0 ml of methylene chloride and a solution of 1.0 g of sodium bisulfate in 5.0 ml of ice water was added. The aqueous phase was extracted three times with 50.0 ml of methylene chloride each time.

  The combined organic phases were dried over Na2SO4, evaporated and dried under high vacuum.



   1.9 g of an orange-colored mass which slowly crystallized through were obtained.



   The recrystallized product (toluene: petroleum ether 1: 1) melted at 92 to 93 "C.



   NMR (CDCl3) 8 = 4.25 (s, 2H); 4.23 (q, J = 7.1 Hz, 2H); 4.03 (t, J = 1.0Hz, 2H); 3.11 (br. S, 2H); 1.30 (t, J = 7.1 Hz, 3H).



  Preparation of 4-hydroxy-2-oxo-pyrrolidin-1-yl-ethyl acetate
54 g (14.5 mmol) of sodium borohydride were added to 8.8 g (47.5 mmol) of ethyl 2,4-dioxopyrrolidin-1-ethyl acetate in 200 ml of dimethoxyethane. The mixture was added stirred for one hour at room temperature. After cooling to 0 ° C., an excess of concentrated hydrochloric acid was added and the inorganic residue was filtered off. The filtrate was evaporated to dryness. The residue was taken up in chloroform, dried over Na2SO4 and evaporated again under vacuum.



   8.8 g of the product resulted in an oily form.



   A subsequent distillation at 180 "C / 1.0 mbar led to 5.3 g (60%) of a colorless oil.



   IR (film) 3400cm-1 (OH); 1740 cm-1 (C = O); 1680 cm- '(C = O); 1200 cm-l Production of 4-hydroxy-2-oxo-pyrrolidin-1-yl-acetamide
13.7 g (73 mmol) of 4-hydroxy-2-oxo-pyrrolidin-1-yl-acetic acid ethyl ester were dissolved in 500 ml of methanol and saturated with ammonia at D "C. Thereafter, the mixture was kept at room temperature for one hour. Evaporation the solvent in vacuo gave a solid residue which was crystallized in methanol.

 

   7.17 g (62%) of the product resulted in the form of a white powder. Mp 165 to 168 "C.



   IR (Nujol) 3400 cm-1, 3300 cm- ', 3250 cm- (OH and NH) 1660 cm-l (C = O).


    

Claims (3)

PATENTANSPRÜCHE 1. Verfahren zur Herstellung von 4-Hydroxy-2-oxo-pyr rolidin- 1 -yl-acetamid, dadurch gekennzeichnet, dass man 4-(C 1-C2)-alkoxy-3-pyrrolin-2-on- 1 -yl-essigsäure-(C1-C4)-al- kylester der Formel EMI1.1 worin R1 = Alkyl mit 1 bis 2 C-Atomen und R2 = Alkyl mit 1 bis 4 C-Atomen bedeutet, mit Trichlormethylsilan in Gegenwart eines Alkalijodids zum 2,4-Dioxo-pyrrolidin- 1 yl-essigsäure-(C 1-C4)-alkylester umsetzt, diesen isoliert und anschliessend mit Natriumborhydrid zu einem 4-Hydroxy-2 oxo-pyrrolidin-l -yl-essigsäure-C1-C4-alkylester hydriert und schliesslich durch Amidierung mittels Ammoniak den 4-Hydroxy-2-oxo-pyrrolidin- l-yl-essigsäure-C1-C4-alkylester in das gewünschte Endprodukt überführt.  PATENT CLAIMS 1. Process for the preparation of 4-hydroxy-2-oxopyrrolidin-1-yl acetamide, characterized in that 4- (C 1 -C 2) alkoxy-3-pyrrolin-2-one-1-yl -acetic acid (C1-C4) alkyl ester of the formula EMI1.1  where R1 = alkyl having 1 to 2 carbon atoms and R2 = alkyl having 1 to 4 carbon atoms, with trichloromethylsilane in the presence of an alkali iodide to give 2,4-dioxopyrrolidin-1-yl-acetic acid (C 1 -C 4) alkyl ester, isolated and then hydrogenated with sodium borohydride to a 4-hydroxy-2 oxo-pyrrolidin-1-yl-acetic acid C1-C4-alkyl ester and finally the 4-hydroxy-2-oxo-pyrrolidine by amidation with ammonia C1-C4-alkyl-1-yl-acetic ester converted into the desired end product.   2. Verfahren gemäss Patentanspruch 1, dadurch gekennzeichnet, dass man 4-Methoxy-3-pyrrolin-2-on-1-yl-essigsäu- reethylester mit Trichlormethylsilan in Gegenwart von Natriumjodid zum 2,4-Dioxo-pyrrolidin- l-yl-essigsäureethyl- ester umsetzt, diesen isoliert und anschliessend mit Natriumborhydrid zum 4-Hydroxy-2-oxo-pyrrolidin- 1-yl-essigsäu- reethylester hydriert und schliesslich durch Amidierung mittels Ammoniak den 4-Hydroxy-2-oxo-pyrrolidin- 1 -yl-essig- säureethylester zum Endprodukt umsetzt.  2. The method according to claim 1, characterized in that 4-methoxy-3-pyrrolin-2-one-1-yl-ethyl acetate with trichloromethylsilane in the presence of sodium iodide to form 2,4-dioxopyrrolidin-l-yl reacted ethyl acetate, isolated this and then hydrogenated with sodium borohydride to give 4-hydroxy-2-oxo-pyrrolidin-1-yl-acetic acid ester and finally the 4-hydroxy-2-oxo-pyrrolidin-1-yl by amidation with ammonia -acetic acid ethyl ester to the end product. 3. Verfahren gemäss einem der Patentansprüche 1 oder 2, dadurch gekennzeichnet, dass die Umsetzung zum 2,4-Di oxo-pyrrolidin-l -yl-essigsäure-(C1-C2)-alkylester in Acetonitril als Lösungsmittel durchgeführt wird.  3. The method according to any one of claims 1 or 2, characterized in that the reaction to 2,4-di oxo-pyrrolidin-l -yl-acetic acid (C1-C2) alkyl ester in acetonitrile is carried out as a solvent.
CH412685A 1985-09-24 1985-09-24 4-Hydroxy-2-oxo-1-pyrrolidinyl-acetamide prodn. CH664957A5 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
CH412685A CH664957A5 (en) 1985-09-24 1985-09-24 4-Hydroxy-2-oxo-1-pyrrolidinyl-acetamide prodn.
IL80071A IL80071A0 (en) 1985-09-24 1986-09-17 Pyrrolidine acetamide derivatives
EP86112952A EP0216325A3 (en) 1985-09-24 1986-09-19 Process for the preparation of 4-hydroxy-2-oxo-pyrrolidin-1-yl-acetamide
JP22177186A JPS6272661A (en) 1985-09-24 1986-09-19 Manufacture of 4-hydroxy-2-oxo-pyrrolidine-1-yl-acetamide
NO863769A NO863769L (en) 1985-09-24 1986-09-22 PROCEDURE FOR THE PREPARATION OF 4-HYDROXY-2-OXOPYRROLIN-1-YL-ACETAMIDE.
ES8602069A ES2001696A6 (en) 1985-09-24 1986-09-22 Process for the preparation of 4-hydroxy-2-oxo-pyrrolidin-1-yl-acetamide.
SU864028166A SU1482525A3 (en) 1985-09-24 1986-09-23 Method of producing 4-oxy-2-oxopyrrolidine-1-yl acetamide
DK453586A DK453586A (en) 1985-09-24 1986-09-23 METHOD OF PREPARING 4-HYDROXY-2-OXO-PYRROLIDIN-1-YL-ACETAMIDE
HU864071A HUT43039A (en) 1985-09-24 1986-09-24 Process for preparing 4-hydroxy-2-oxo-pyrrolidin-1-yl-acetamide
CS866880A CS257294B2 (en) 1985-09-24 1986-09-24 Productionmethod of 4-hydroxy-2-oxo-pyrrolidin-1-yl-acetamid
US07/188,702 US4824966A (en) 1985-09-24 1988-05-04 Process for the production of 4-hydroxy-2-oxo-pyrrolidin-1-yl acetamide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH412685A CH664957A5 (en) 1985-09-24 1985-09-24 4-Hydroxy-2-oxo-1-pyrrolidinyl-acetamide prodn.

Publications (1)

Publication Number Publication Date
CH664957A5 true CH664957A5 (en) 1988-04-15

Family

ID=4270309

Family Applications (1)

Application Number Title Priority Date Filing Date
CH412685A CH664957A5 (en) 1985-09-24 1985-09-24 4-Hydroxy-2-oxo-1-pyrrolidinyl-acetamide prodn.

Country Status (4)

Country Link
JP (1) JPS6272661A (en)
CH (1) CH664957A5 (en)
CS (1) CS257294B2 (en)
SU (1) SU1482525A3 (en)

Also Published As

Publication number Publication date
SU1482525A3 (en) 1989-05-23
JPS6272661A (en) 1987-04-03
CS688086A2 (en) 1987-09-17
CS257294B2 (en) 1988-04-15

Similar Documents

Publication Publication Date Title
DE3043252A1 (en) CYCLIC ACETALS OF N-ACYLGLUTAMIN ACID (GAMMA) SEMIALDEHYDES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE
DE60225008T2 (en) PROCESS FOR PREPARING THE PIPERIDINE DERIVATIVE FEXOFENADINE
EP0276329B1 (en) 2,3-diaminoacrylonitrile derivatives
EP0216324B1 (en) 4-alkoxy-3-pyrrolin-2-one-1-yl-acetic acid alkyl and benzyl esters and their preparation
CH664957A5 (en) 4-Hydroxy-2-oxo-1-pyrrolidinyl-acetamide prodn.
SU747425A3 (en) Method of producing derivatives of aminoalkoxybenzofuranes
EP0202625B1 (en) Process for the preparation of 2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-(n-benzyl-n-methylamino)-ethyl ester 5-methyl ester and its hydrochloride salt
EP0216325A2 (en) Process for the preparation of 4-hydroxy-2-oxo-pyrrolidin-1-yl-acetamide
US4250312A (en) Process for preparing 4-piperidone spiroketal compounds
EP0252363B1 (en) 4-benzyloxy-3-pyrrolin-2-one, preparation and use in the synthesis of 2,4-pyrrolidinedione
DE10019291C2 (en) 2-alkoxy-5-methoxypyrimidines or their tautomeric forms and processes for their preparation
EP0224256A1 (en) Alkyl-4-alkoxy-2-oxo-pyrrolidin-1-yl acetate
DE2707404C3 (en) Process for the preparation of 5,6-dehydropenicillins
CH624107A5 (en)
EP0133493A2 (en) Process for the preparation of carbohydrates
EP0087657B1 (en) Process for the preparation of 1-(4-chlorbenzoyl)-5-methoxy-2-methyl-3-indolylacetoxy-acetic acid
CH666481A5 (en) 4-Hydroxy-2-oxo-1-pyrrolidinyl-acetamide prodn.
US4144245A (en) 4-Hydroxymethyl-2-pyrrolidinones
DE3004684C2 (en) Process for the preparation of cis-bicyclo [3.3.0] octane-3,7-dione
EP0446925B1 (en) Process for the preparation of beta-resorcylic acid derivatives
EP0087654B1 (en) Process for the preparation of 1-(4-chlorbenzoyl)-5-methoxy-2-methyl-3-indolylacetoxy-acetic acid
DE3640583A1 (en) METHOD FOR PRODUCING 6-HYDROXY-3-PYRIDINE CARBONIC ACID ESTERS
DE2705874C2 (en) Process for the preparation of phloroglucinol and phloroglucinol derivatives
AT381938B (en) METHOD FOR PRODUCING NEW SPIROBENZOFURANONE COMPOUNDS
CH649291A5 (en) DICARBAMATE.

Legal Events

Date Code Title Description
PL Patent ceased